Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2007 2
2008 2
2009 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial.
Wallner C, Lange MM, Bonsing BA, Maas CP, Wallace CN, Dabhoiwala NF, Rutten HJ, Lamers WH, Deruiter MC, van de Velde CJ; Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial. Wallner C, et al. J Clin Oncol. 2008 Sep 20;26(27):4466-72. doi: 10.1200/JCO.2008.17.3062. J Clin Oncol. 2008. PMID: 18802159
Risk factors for sexual dysfunction after rectal cancer treatment.
Lange MM, Marijnen CA, Maas CP, Putter H, Rutten HJ, Stiggelbout AM, Meershoek-Klein Kranenbarg E, van de Velde CJ; Cooperative clinical investigators of the Dutch. Lange MM, et al. Eur J Cancer. 2009 Jun;45(9):1578-88. doi: 10.1016/j.ejca.2008.12.014. Epub 2009 Jan 13. Eur J Cancer. 2009. PMID: 19147343 Clinical Trial.
No downstaging after short-term preoperative radiotherapy in rectal cancer patients.
Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, van Krieken JH; Pathology Review Committee and the Cooperative Clinical Investigators. Marijnen CA, et al. J Clin Oncol. 2001 Apr 1;19(7):1976-84. doi: 10.1200/JCO.2001.19.7.1976. J Clin Oncol. 2001. PMID: 11283130 Free article. Clinical Trial.
Risk factors for faecal incontinence after rectal cancer treatment.
Lange MM, den Dulk M, Bossema ER, Maas CP, Peeters KC, Rutten HJ, Klein Kranenbarg E, Marijnen CA, van de Velde CJ; Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial. Lange MM, et al. Br J Surg. 2007 Oct;94(10):1278-84. doi: 10.1002/bjs.5819. Br J Surg. 2007. PMID: 17579345 Clinical Trial.
Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.
Gosens MJ, van Krieken JH, Marijnen CA, Meershoek-Klein Kranenbarg E, Putter H, Rutten HJ, Bujko K, van de Velde CJ, Nagtegaal ID; Cooperative Clinical Investigators and the Pathology Review Committee. Gosens MJ, et al. Clin Gastroenterol Hepatol. 2007 Aug;5(8):997-1003. doi: 10.1016/j.cgh.2007.03.016. Epub 2007 Jun 4. Clin Gastroenterol Hepatol. 2007. PMID: 17544876 Clinical Trial.
Urinary dysfunction after rectal cancer treatment is mainly caused by surgery.
Lange MM, Maas CP, Marijnen CA, Wiggers T, Rutten HJ, Kranenbarg EK, van de Velde CJ; Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial. Lange MM, et al. Br J Surg. 2008 Aug;95(8):1020-8. doi: 10.1002/bjs.6126. Br J Surg. 2008. PMID: 18563786 Clinical Trial.
Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer.
Lange MM, van Hilten JA, van de Watering LM, Bijnen BA, Roumen RM, Putter H, Brand A, van de Velde CJ; cooperative clinical investigators of the Cancer Recurrence And Blood Transfusion (CRAB) study and the Transfusion Associated Complications = Transfusion Induced Complications? (TACTIC) study. Lange MM, et al. Br J Surg. 2009 Jul;96(7):734-40. doi: 10.1002/bjs.6636. Br J Surg. 2009. PMID: 19526613 Clinical Trial.